Heart failure (HF) has for several years dominated cardiology headlines, but 2023 offered fewer blockbusters and plenty of debate over how key clinical trial results should impact HF care. But a ...
ESC 2021 Shadow of LVEF-based HF Categories Looms Over New ESC Guideline It was hard not to think of the upcoming presentation on EMPEROR-Preserved, with its potentially profound impact on HF ...
Reclassifying HFmrEF as a stable phenotype aims to reduce therapeutic inertia and GDMT underuse driven by heterogeneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results